Skip to main content

Table 3 Univariate and multivariate logistic regression analysis for I-LGE in HCM patients

From: Focal ischemic myocardial fibrosis assessed by late gadolinium enhancement cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy

 

Univariate analysis

Multivariate analysis

Variable

OR (95% CI); P-value

OR (95% CI); P-value

LVEDV

1.007 (0.996–1.019); P = 0.208

-

LVESV

1.012 (0.998–1.027); P = 0.083

-

LVSV

0.996 (0.976–1.018); P = 0.739

-

LVEF

0.961 (0.930–0.993); P = 0.016

0.948 (0.910–0.989); P = 0.013

LVCO

0.980 (0.720–1.334); P = 0.896

-

LV mass

1.028 (1.015–1.042); P < 0.001

1.010 (0.993–1.027); P = 0.254

The maximal end-diastolic LVWT

1.567 (1.288–1.908); P < 0.001

1.548 (1.204–1.990); P = 0.001

  1. HCM hypertrophic cardiomyopathy, I-LGE ischemic myocardial fibrosis assessed by late gadolinium enhancement, LV left ventricular, LVEF left ventricular ejection fraction, LVEDV left ventricular end-diastolic volume, LVESV left ventricular end-systolic volume, LVSV left ventricular stroke volume, LVWT left ventricular wall thickness